22
7
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T22414 |
RBN012759
|
PARP | Chromatin/Epigenetic; DNA Damage/DNA Repair |
RBN012759 是选择性和具有口服活性的 PARP14抑制剂,IC50值小于3 nM,可降低促肿瘤巨噬细胞功能并在肿瘤外植体中引发炎症反应,比对 monoPARPs 的选择性高 300 倍,比对 polyPARPs 的选择性高 1000 倍。 | |||
T76371 |
Tumor targeted pro-apoptotic peptide
|
||
Tumor targeted pro-apoptotic peptide (CNGRC-GG-D(KLAKLAK)2) 为抗肿瘤肽,具有破坏线粒体膜和促进细胞凋亡功能,展现小鼠的抗癌活性。 | |||
T4169 |
N-Nitroso-N-methylurea
1-甲基-1-亚硝基脲,1-Methyl-1-nitrosourea,N-Methyl-N-nitrosourea,Methylnitrosourea |
Others; DNA Alkylator/Crosslinker | DNA Damage/DNA Repair; Others |
N-Nitroso-N-methylurea (Methylnitrosourea) 是一种具有烷基化、致癌和致突变特性的亚硝基脲化合物。它靶向多种动物器官,可引起各种癌症和变性疾病,可用于重氮甲烷合成。 | |||
T77059 |
Leronlimab
PRO 140 |
CCR | Immunology/Inflammation; Microbiology/Virology |
Leronlimab (PRO 140) 是一种人源化 IgG4 抗 CCR5 单克隆抗体。leronlimumab 具有抗 HIV 病毒活性和抗肿瘤活性, 抑制 CCR 介导的 HIV-1 病毒和小鼠肿瘤模型中癌细胞转移。Leronlimab 可用于研究 HIV 非酒精性脂肪性肝炎 (NASH) 和乳腺癌。 | |||
T14075 |
A-802715
|
IL Receptor | Immunology/Inflammation |
A-802715 是一种新型甲基黄嘌呤衍生物,可降低促炎物质的内源性形成和血液水平,并增加白细胞介素10受体和肿瘤坏死因子受体等抗炎物质的形成和血液水平。 | |||
T31020 |
CP 461
OSI 461,UNII-68OJX9I7DT,CP-461,CP461 |
Apoptosis; PDE | Apoptosis; Metabolism |
CP 461 (UNII-68OJX9I7DT) 是一种特异性 PDE2A 抑制剂,是一种新型促凋亡化合物,能抑制环 GMP 磷酸二酯酶,但不能抑制环氧化酶-1 或-2。CP 461 在体外可抑制多种人类肿瘤细胞系的生长,并选择性地诱导癌细胞系而不是正常细胞凋亡。 | |||
T15594 |
MKC8866
|
IRE1 | Cell Cycle/Checkpoint |
MKC8866 是一种选择性IRE1 RNase 抑制剂,在体外的IC50为 0.29 μM,是水杨醛类似物。 它抑制乳腺癌细胞中的 IRE1 RNase,导致促肿瘤因子的产生减少,并且可以抑制前列腺癌 (PCa) 肿瘤的生长。它强烈抑制二硫苏糖醇诱导的 XBP1s 表达,EC50为 0.52 μM。 | |||
T77493 |
Murlentamab
3C23K,GM102 |
Others | Others |
Murlentamab (GM102) 是一种人源化抗 AMHRII 抗体。Murlentama 具有潜在的抗肿瘤活性,可诱导巨噬细胞介导的抗体依赖的细胞介导的细胞毒性作用 (ADCC)。Murl可通过募,集、活化T细胞激发促炎和抗肿瘤内环境。Murlentama 通过促进幼稚的巨噬细胞定向,促进肿瘤相关巨噬细胞 (TAM) 重编程来发挥抗肿瘤活性。 | |||
T67924 |
ABzOH
|
||
ABzOH 是一种苯甲酸衍生物,结构类似于阿司匹林等非甾体抗炎药,具有抗炎、抗肿瘤和抗增殖作用。ABzOH 不仅可以抑制肿瘤坏死因子- α (TNF-a)、白细胞介素-1β (IL-1β)和白细胞介素-6 (IL-6)等促炎细胞因子的表达还对乳腺癌、肺癌和胰腺癌具有抑制作用。 | |||
T1185 |
Rofecoxib
MK 966,罗非昔布,罗非考昔,MK-0966 |
COX | Immunology/Inflammation; Neuroscience |
Rofecoxib (MK 966) 是可口服的 COX-2特异性抑制剂,具有抗炎、解热和镇痛特性以及潜在的抗肿瘤特性。在人骨肉瘤细胞和中国仓鼠卵巢细胞中,对人 COX-2 的 IC50值分别为 26 和 18 nM。 | |||
T60202 |
MMRi62
7-[(2,3-dichlorophenyl)-(pyridin-2-ylamino)methyl]quinolin-8-ol |
Ferroptosis | Apoptosis |
MMRi62 (7-[(2,3-dichlorophenyl)-(pyridin-2-ylamino)methyl]quinolin-8-ol) 是一种铁死亡 (ferroptosis) 诱导剂,靶向 MDM2-MDM4 (抑癌基因 p53 负调控因子)。MMRi62 对胰腺导管腺癌 (PDAC) 细胞显示出 p53 独立的促凋亡 (apoptosis) 活性,并诱导其自噬 (autophagy)。MMRi62 诱导铁死亡,伴随着活性氧增加和铁蛋白重链 (FTH1) 溶酶体降解。MMRi62 还可导致突变型 p53 的蛋白酶体降解,并对具有 KRAS 和 TP53 高频突变特征的原位异种移植 PDAC 小鼠模型具有体内药效。 | |||
T38406 |
L-Proline 4-methoxy-β-naphthylamide hydrochloride
H-Pro-4MβNA hydrochloride,L-Proline 4-methoxy-β-naphthylamide hydrochloride |
||
L-Proline 4-methoxy-β-naphthylamide hydrochloride, also known as H-Pro-4MβNA hydrochloride, is a chemical compound utilized in the preparation of Fap-activated anti-tumor compounds. | |||
T80687 |
γ3-MSH
|
||
γ3-MSH 源于 pro-opiomelanocortin (POMC) 的 N 端,能够激活人肾上腺肿瘤细胞分泌醛固酮。 | |||
T69599 |
ABT-510
|
||
ABT-510 is synthetic peptide that mimics the anti-angiogenic activity of the endogenous protein thrombospondin-1 (TSP-1). ABT-510 inhibits the actions of several pro-angiogenic growth factors important to tumor neovascularization; these pro-angiogenic growth factors include vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF)), hepatocyte growth factor (HGF), and interleukin 8 (IL-8). | |||
T82633 |
Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2
|
||
Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2是源自层粘连蛋白B1链的线性肽,能够干预肿瘤细胞对基底膜的附着与侵袭,且表现出抗血管生成活性。 | |||
T80127 |
FITC-Ahx-Gly-Arg-Gly-Asp-Ser-Pro
|
Integrin | Cytoskeletal Signaling |
FITC-Ahx-Gly-Arg-Gly-Asp-Ser-Pro为FITC标记的GRGDSP,后者为整联蛋白(integrin)抑制剂,能阻止肿瘤细胞与血管内皮细胞粘附,进而抑制肿瘤转移。 | |||
T69821 |
AMP423
|
||
AMP423 is a naphthyl derivative of 2-cyanoaziridine-1-carboxamide with structural similarity to the pro-oxidant anti-tumor agent imexon. AMP423 was active in SCID mice bearing 8226/S myeloma and SU-DHL-6 B-cell lymphoma tumors, with a median tumor growth delay (T-C) of 21 days (P = 0.0002) and 5 days (P = 0.004), respectively, and a median tumor growth inhibition (T/C) of 33.3% (P = 0.03) and 82% (P = 0.01), respectively. In non-tumor-bearing mice, AMP423 was not myelosuppressive. | |||
T69223 | CC-1088 | ||
CC-1088 is an analog of thalidomide with potential antineoplastic activity that belongs to the functional class of agents called selective cytokine inhibitory drugs (SelCIDs). SelCIDs inhibit phosphodiesterase-4 (PDE 4), an enzyme involved in tumor necrosis factor alpha (TNF alpha) production. CC-1088 inhibits production of the cytokines vascular endothelial growth factor (VEGF) (a pro-angiogenic factor) and interleukin-6 (IL-6). | |||
T76315 |
HKPao
|
||
HKPao (Hunter-killer peptide ao) 是一种具有抗肥胖和抗肿瘤促凋亡活性的生物活性肽,能够促使细胞释放囊泡中的细胞色素 c。 | |||
T72570 |
Antitumor agent-83
|
||
Antitumor agent-83 是一种促凋亡蛋白 BAX 的激活剂,对肿瘤细胞有显著的抗增殖作用。Antitumor agent-83 通过诱导 BAX 的构象激活介导细胞凋亡 (Apoptosis),对 A549 细胞周期有抑制作用。Antitumor agent-83 具有良好的体外代谢稳定性和 CYP 谱。 | |||
T28874 |
SU11652
SU-11652,SU 11652 |
||
SU11652 is a potent cell-permeable pyrrole-indolinone compound. SU11652 acts as an ATP-competitive tyrosine kinase receptor and angiogenic inhibitor with greater selectivity for PDGFR-β (PDGFRβ, IC50 = 3 nM), Flk-1 (VEGFR2, IC50 = 27 nM), FGFR1 (IC50= 170 | |||
T37861 | Talabostat | ||
Talabostat (PT100, Val-boroPro) is a potent, nonselective and orally available dipeptidyl peptidase IV (DPP-IV) inhibitor with a Ki of 0.18 nM. Talabostat is a nonselective DPP-IV inhibitor, inhibiting DPP8/9, FAP, DPP2 and some other DASH family enzymes essentially as potently as it inhibits DPP-IV[1]. Talabostat stimulates the immune system by triggering a proinflammatory form of cell death in monocytes and macrophages known as pyroptosis. The inhibition of two serine proteases, DPP8 and DPP9,... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8193 |
α-Thujone
Thujone,ALPHA-(-)-THUJONE,α-侧柏酮,(-)-α-侧柏酮 |
Apoptosis; Reactive Oxygen Species; GABA Receptor; AChR; Parasite; Autophagy | Apoptosis; Autophagy; Immunology/Inflammation; Membrane transporter/Ion channel; Metabolism; Microbiology/Virology; Neuroscience; NF-κB |
α-Thujone 是一种从西方金钟柏精油中分离出来的单萜,可穿透血脑屏障。它是 GABAA 受体的可逆调节剂,在抑制 GABA 诱导的电流时,它的 IC50为 21 μM。它诱导 ROS 依赖性细胞毒性,还诱导细胞凋亡和自噬。它具有抗伤害,抗肿瘤、杀虫和驱虫活性。 | |||
TN1291 |
7,3',4'-Tri-O-methylluteolin
5-Hydroxy-3',4',7-trimethoxyflavone,木犀草素-7,3',4'-三甲醚 |
TNF; COX; Interleukin | Apoptosis; Immunology/Inflammation; Neuroscience |
7,3',4'-Tri-O-methylluteolin (5-Hydroxy-3',4',7-trimethoxyflavone) 是来自草药马鞭草科的一种类黄酮,具有抗炎,解热,镇咳,抗糖尿病、抗癌和抗黑素生成特性。它以浓度依赖方式明显抑制促炎细胞因子,可显著降低在转录水平的诱导型一氧化氮合酶和环加氧酶-2 的 mRNA 表达。 | |||
T3395 |
Timosaponin AIII
Filiferin B,知母皂苷 A-III,AneMarsaponin A3,Timosaponin A3 |
AChE; mTOR | Neuroscience; PI3K/Akt/mTOR signaling |
Timosaponin AIII (Timosaponin A3) 是一种乙酰胆碱酯酶活性抑制剂,其IC50=35.4 μM。 | |||
T3S0737 |
Flavokawain A
2'-羟基-4,4',6'-三甲氧基查耳酮,Flavokavain A |
Apoptosis; p38 MAPK | Apoptosis; MAPK |
Flavokawain A (Flavokavain A) 是 kava 提取物中的查耳酮,是一种抗癌试剂,具有抗肿瘤活性。它通过 Bax 蛋白依赖和线粒体依赖的凋亡途径诱导细胞凋亡,有潜力用于膀胱癌的相关研究。 | |||
T36715 |
Tetrac
Tetraiodothyroacetic acid,3,3',5,5'-Tetraiodothyroacetic acid |
Apoptosis; EGFR | Angiogenesis; Apoptosis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Tetrac (Tetraiodothyroacetic acid)是L-甲状腺素(T4)的衍生物,是一种甲状腺整合素受体拮抗剂。Tetrac通过阻断EGFR介导的结直肠癌细胞信号传导来诱导抗增殖。Tetrac 可阻断 T4 和 3,5,3'-triiodo-L-thyronine (T3)在细胞表面甲状腺素整合素 αvβ3 受体上的作用。Tetra 具有抗血管生成、抗肿瘤活性和促凋亡活性。 | |||
T2S2264 |
Linalool
Linalol,(±)-Linalool,Phantol,沉香醇 |
Apoptosis; IL Receptor; TNF; Endogenous Metabolite; iGluR | Apoptosis; Immunology/Inflammation; Membrane transporter/Ion channel; Metabolism; Neuroscience |
Linalool (Linalol) 是存在芫荽等植物中的单萜类天然产物,是竞争性NMDA 受体拮抗剂,具有抗肿瘤和抗心脏毒性的作用。它通过激活 Nrf2 诱导抗氧化防御和通过抑制 NF-κB 减少炎症反应来保护其免受 LPS/GalN 诱导的肝损伤,具有镇痛、抗菌和抗炎的特性。 | |||
TMA2576 |
Episappanol
|
IL Receptor; TNF | Apoptosis; Immunology/Inflammation |
Episappanol has anti-inflammatory activity , it can significantly inhibit the secretion of the pro-inflammatory cytokines interleukin (IL-6) and tumor necrosis factor-alpha (TNF-α). |